Global Clinical Compliance
Ferring Pharmaceuticals · Ferring Pharmaceutical
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Global Clinical Compliance as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:34 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07152730 · A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod PumpFerring Pharmaceuticals · withdrawn · Amenorrhea, Fertility, Infertility · study director
- N/ANCT07029451 · To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world PracticeFerring Pharmaceuticals · active not recruiting · Infertility · study director
- Ph1/Ph2NCT06668493 · Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal PelvisFerring Pharmaceuticals · recruiting · Low-grade Upper Tract Urothelial Carcinoma · study director
- N/ANCT06561958 · Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World SettingsFerring Pharmaceuticals · active not recruiting · Infertility · study director
- N/ANCT06545877 · REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)Ferring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT06545955 · A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerFerring Pharmaceuticals · recruiting · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ · study director
- Ph1NCT06515834 · Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese PersonsFerring Pharmaceuticals · completed · Gastroenterology · study director
- Ph3NCT06510374 · Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerFerring Pharmaceuticals · recruiting · Intermediate Risk Non-Muscle Invasive Bladder Cancer · study director
- Ph1NCT06466486 · An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian StimulationFerring Pharmaceuticals · terminated · Fertility · study director
- Ph4NCT06390111 · A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.Ferring Pharmaceuticals · withdrawn · Bladder Cancer, Ta/T1, CIS · study director
- Ph1NCT06298032 · A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy PersonsFerring Pharmaceuticals · completed · Inflammatory Gastrointestinal Diseases · study director
- Ph1NCT06260267 · A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative ColitisFerring Pharmaceuticals · withdrawn · Ulcerative Colitis · study director
- Ph3NCT06173869 · A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in ChinaFerring Pharmaceuticals · completed · Infertility, Female · study director
- N/ANCT06026332 · ADSTILADRIN Early Utilization and Outcomes in the Real World SettingFerring Pharmaceuticals · terminated · Bladder Cancer · study director
- Ph1NCT05924321 · A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy SubjectsFerring Pharmaceuticals · completed · Postpartum Hemorrhage · study director
- N/ANCT05835219 · REBYOTA™ Prospective RegistryFerring Pharmaceuticals · completed · Recurrence of Clostridium Difficile Infection · study director
- Ph3NCT05831189 · A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionFerring Pharmaceuticals · completed · Clostridium Difficile Infection Recurrence · study director
- Ph3NCT05704244 · Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)Ferring Pharmaceuticals · active not recruiting · Bladder Cancer · study director
- Ph2NCT05571111 · Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian StimulationFerring Pharmaceuticals · withdrawn · Infertility · study director
- N/ANCT05499052 · Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical PracticeFerring Pharmaceuticals · completed · Controlled Ovarian Stimulation · study director
- Ph2NCT05403476 · A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)Ferring Pharmaceuticals · terminated · Male Idiopathic Infertility · study director
- Ph3NCT05263388 · A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian StimulationFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT05181800 · FIRMAGON® Intensive Drug MonitoringFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph1NCT04902131 · A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy WomenFerring Pharmaceuticals · completed · Infertility, Female · study director
- N/ANCT04876300 · MEDAM (Menopur Retrospective Data prograM)Ferring Pharmaceuticals · completed · Infertility, Female · study director
- N/ANCT04852120 · Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese PopulationFerring Pharmaceuticals · completed · Bowel Cleansing · study director
- N/ANCT04814940 · Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility TreatmentFerring Pharmaceuticals · withdrawn · Infertility, Female · study director
- Ph3NCT04773353 · Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian WomenFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT04773314 · General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)Ferring Pharmaceuticals · completed · Cervical Ripening, Pregnancy · study director
- N/ANCT04740645 · NOCDURNA PASS Study Using Registries in Denmark, Germany and SwedenFerring Pharmaceuticals · completed · Adverse Drug Event · study director
- N/ANCT04654039 · Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)Ferring Pharmaceuticals · completed · Infertility, Female · study director
- N/ANCT04503707 · Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical PracticeFerring Pharmaceuticals · completed · Controlled Ovarian Stimulation · study director
- N/ANCT04499495 · Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in KoreaFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- N/ANCT04340895 · Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)Ferring Pharmaceuticals · completed · Mild-to-moderate Ulcerative Colitis · study director
- N/ANCT04329975 · Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)Ferring Pharmaceuticals · completed · Nocturia Due to Nocturnal Polyuria · study director
- Ph3NCT04163458 · Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)Ferring Pharmaceuticals · completed · Infertility · study director
- Ph1NCT04150861 · Rekovelle PK Trial in Chinese WomenFerring Pharmaceuticals · completed · Infertility · study director
- N/ANCT04125186 · A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the USFerring Pharmaceuticals · completed · Nocturnal Polyuria · study director
- Ph1NCT04080713 · Cortiment® MMX Pharmacokinetic StudyFerring Pharmaceuticals · completed · Healthy · study director
- Ph3NCT03809429 · Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)Ferring Pharmaceuticals · completed · Infertility, Female · study director
- Ph2NCT03749109 · Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/AdenomyosisFerring Pharmaceuticals · completed · Endometriosis · study director
- Ph3NCT03740737 · Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)Ferring Pharmaceuticals · completed · Infertility · study director
- Ph3NCT03738618 · Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)Ferring Pharmaceuticals · completed · Infertility, Female · study director
- N/ANCT03697031 · Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®Ferring Pharmaceuticals · terminated · Controlled Ovarian Stimulation · study director
- Ph2NCT03692403 · Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related PainFerring Pharmaceuticals · completed · Endometriosis-related Pain · study director
- N/ANCT03631446 · Drug Use-Results Survey on Picoprep® Combination PowderFerring Pharmaceuticals · completed · Bowel Cleansing · study director
- Ph3NCT03565211 · Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology ProceduresFerring Pharmaceuticals · completed · Progesterone Supplementation in Women Undergoing ART · study director
- Ph2NCT03564509 · A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.Ferring Pharmaceuticals · completed · Controlled Ovarian Stimulation · study director
- Ph3NCT03412682 · To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative ColitisFerring Pharmaceuticals · completed · Colitis, Ulcerative · study director
- Ph3NCT03296527 · Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian WomenFerring Pharmaceuticals · completed · Controlled Ovarian Simulation · study director
- N/ANCT03274973 · Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner SyndromeFerring Pharmaceuticals · terminated · Growth Disorders · study director
- Ph3NCT03228680 · Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese WomenFerring Pharmaceuticals · completed · Infertility · study director
- Ph2NCT03201419 · A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in AdultsFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT03193645 · Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With DegarelixFerring Pharmaceuticals · completed · Prostate Cancer · study director
- N/ANCT03089073 · Study of Minirin Melt® in Adult Patients With NocturiaFerring Pharmaceuticals · terminated · Nocturia · study director
- N/ANCT03028415 · AMPLEX Ankle Fusion and HindfootFerring Pharmaceuticals · completed · Arthrodesis Surgery Involving the Hindfoot or Ankle · study director
- Ph1NCT02929407 · A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal HypertensionFerring Pharmaceuticals · terminated · Portal Hypertension · study director
- Ph3NCT02905682 · Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female SubjectsFerring Pharmaceuticals · completed · Nocturia · study director
- Ph3NCT02904759 · Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male SubjectsFerring Pharmaceuticals · completed · Nocturia · study director
- N/ANCT02886598 · Safety and Efficacy of Firmagon® (Degarelix) for InjectionFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph4NCT02726009 · A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate CancerFerring Pharmaceuticals · completed · Prostate Cancer · study director
- Ph3NCT02663908 · A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseFerring Pharmaceuticals · terminated · Prostate Cancer · study director
- N/ANCT02586259 · Effectiveness of Cortiment® in Patients With Ulcerative ColitisFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph4NCT02554279 · MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject PopulationFerring Pharmaceuticals · completed · Infertility · study director
- Ph2NCT02545127 · Merotocin in Mothers With Inadequate Milk Production and Infants Delivered PrematurelyFerring Pharmaceuticals · terminated · Preterm Delivery, Inadequate Milk Production · study director
- Ph3NCT02522767 · Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)Ferring Pharmaceuticals · completed · Ulcerative Colitis · study director
- Ph3NCT02522780 · Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)Ferring Pharmaceuticals · completed · Ulcerative Colitis · study director
- N/ANCT02261636 · Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis TreatmentFerring Pharmaceuticals · completed · Ulcerative Colitis · study director
- N/ANCT02234089 · Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.Ferring Pharmaceuticals · completed · Advanced Prostate Cancer · study director
- N/ANCT02193048 · Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's DiseaseFerring Pharmaceuticals · completed · Crohn's Disease · study director
- Ph3NCT01976728 · LutrePulse Hypogonadotropic HypogonadismFerring Pharmaceuticals · completed · Primary Amenorrhea With Hypogonadotropic Hypogonadism · study director
- N/ANCT01234350 · A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGONFerring Pharmaceuticals · completed · Prostate Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.